MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Anacor Pharmaceuticals Company Profile (NASDAQ:ANAC)

Consensus Ratings for Anacor Pharmaceuticals (NASDAQ:ANAC) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $150.33 (0.81% upside)

Analysts' Ratings History for Anacor Pharmaceuticals (NASDAQ:ANAC)
Show:
DateFirmActionRatingPrice TargetActions
7/21/2015Bank of AmericaUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2015Goldman SachsUpgradeNeutral -> Buy$195.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/14/2015Jefferies GroupBoost Price TargetBuy$80.00 -> $171.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Jefferies GroupBoost Price TargetBuy$70.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015WedbushBoost Price TargetOutperform$72.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Jefferies GroupBoost Price TargetBuy$57.00 -> $70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2015WedbushBoost Price TargetBuy$72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015Jefferies GroupBoost Price TargetBuy$41.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015WedbushBoost Price TargetOutperform$50.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/16/2015WedbushReiterated RatingOutperform$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015WedbushBoost Price Target$50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2015Jefferies GroupBoost Price TargetBuy$34.00 -> $41.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2014Goldman SachsInitiated CoverageNeutral$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014Avondale PartnersInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Jefferies GroupBoost Price TargetBuy$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014Jefferies GroupReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Jefferies GroupReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014Jefferies GroupReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Jefferies GroupInitiated CoverageBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2013Canaccord GenuityBoost Price TargetBuy$17.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2013Canaccord GenuityBoost Price TargetBuy$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/18/2013WedbushBoost Price Target$20.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/18/2013Deutsche BankBoost Price TargetBuy$11.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/3/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha